How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/megaloblastic-anemia-due-to-folate-deficiency.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Megaloblastic anemia due to folate deficiency — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Megaloblastic anemia due to folate deficiency (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Megaloblastic anemia due to folate deficiency, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Iron Fumarate	FERROUS FUMARATE	Pfizer	Vitamin C [EPC]		1986-01-01
Cyanocobalamin Co 57	cyanocobalamin (57Co)	Mallinckrodt	Radioactive Diagnostic Agent	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial, Methionine synthase, Methionine synthase reductase	1968-01-01
Colace	docusate sodium	Generic (multiple manufacturers)	Stool softener (surfactant laxative)	N/A (surfactant mechanism)	1955-01-01
FERROUS SULFATE	FERROUS SULFATE	Pfizer	ferrous sulfate		1946-01-01
Folic Acid	FOLIC ACID	Pfizer	Vitamin C [EPC]	Thymidylate synthase	1946-01-01
Elemental Iron (As Carbonyl Iron)	Iron	Hippocration General Hospital	Vitamin C [EPC]

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Megaloblastic anemia due to folate deficiency
Pfizer · 3 drugs in Megaloblastic anemia due to folate deficiency
Generic (multiple manufacturers) · 1 drug in Megaloblastic anemia due to folate deficiency
Hippocration General Hospital · 1 drug in Megaloblastic anemia due to folate deficiency
Mallinckrodt · 1 drug in Megaloblastic anemia due to folate deficiency

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Megaloblastic anemia due to folate deficiency:

Cite this brief

Drug Landscape (2026). Megaloblastic anemia due to folate deficiency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/megaloblastic-anemia-due-to-folate-deficiency. Accessed 2026-06-10.

Megaloblastic anemia due to folate deficiency full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing